These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 39253300)

  • 1. Health economic impact of patients with phenylketonuria (PKU) in France - A nationwide study of health insurance claims data.
    Arnoux JB; Douillard C; Maillot F; Bouée S; Jacob C; Schneider KM; Theil J; Charrière S
    Mol Genet Metab Rep; 2024 Dec; 41():101134. PubMed ID: 39253300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health status and comorbidities of adult patients with late-diagnosed phenylketonuria (PKU) born before the newborn screening in France - A nationwide study of health insurance claims data.
    Douillard C; Arnoux JB; Bouée S; Jacob C; Schneider KM; Theil J; Charrière S; Maillot F
    Mol Genet Metab; 2023 Nov; 140(3):107704. PubMed ID: 37812967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health status and comorbidities of adult patients with phenylketonuria (PKU) in France with a focus on early-diagnosed patients - A nationwide study of health insurance claims data.
    Charrière S; Maillot F; Bouée S; Douillard C; Jacob C; Schneider KM; Theil J; Arnoux JB
    Mol Genet Metab; 2023 Jul; 139(3):107625. PubMed ID: 37329624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health economic burden of patients with phenylketonuria (PKU) - A retrospective study of German health insurance claims data.
    Trefz F; Muntau AC; Schneider KM; Altevers J; Jacob C; Braun S; Greiner W; Jha A; Jain M; Alvarez I; Lane P; Zeiss C; Rutsch F
    Mol Genet Metab Rep; 2021 Jun; 27():100764. PubMed ID: 34036045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of comorbid conditions among adult patients diagnosed with phenylketonuria.
    Burton BK; Jones KB; Cederbaum S; Rohr F; Waisbren S; Irwin DE; Kim G; Lilienstein J; Alvarez I; Jurecki E; Levy H
    Mol Genet Metab; 2018 Nov; 125(3):228-234. PubMed ID: 30266197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical burden of illness in patients with phenylketonuria (PKU) and associated comorbidities - a retrospective study of German health insurance claims data.
    Trefz KF; Muntau AC; Kohlscheen KM; Altevers J; Jacob C; Braun S; Greiner W; Jha A; Jain M; Alvarez I; Lane P; Schröder C; Rutsch F
    Orphanet J Rare Dis; 2019 Jul; 14(1):181. PubMed ID: 31331350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel approach to the epidemiology of people living with spinal cord injuries in France based on an original algorithm from public health insurance data.
    Duchaine F; Espagnacq M; Bensmail D; Regaert C; Denys P; Levy J
    J Epidemiol Popul Health; 2024 Oct; 72(5):202773. PubMed ID: 39111117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The financial and time burden associated with phenylketonuria treatment in the United States.
    Rose AM; Grosse SD; Garcia SP; Bach J; Kleyn M; Simon NE; Prosser LA
    Mol Genet Metab Rep; 2019 Dec; 21():100523. PubMed ID: 31660292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Healthcare Resource Consumption and Cost of Invasive Meningococcal Disease in France: A Study of the National Health Insurance Database.
    Weil-Olivier C; Taha MK; Emery C; Bouée S; Beck E; Aris E; Loncle-Provot V; Nachbaur G; Pribil C
    Infect Dis Ther; 2021 Sep; 10(3):1607-1623. PubMed ID: 34170505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the treatment pattern, health care resource utilisation, and economic burden of multiple myeloma in France using the Système National des Données de Santé (SNDS) database: a retrospective cohort study.
    Bessou A; Colin X; De Nascimento J; Sopwith W; Ferrante S; Gorsh B; Gutierrez B; Sansbury L; Willson J; Sapra S; Paka P; Wang F
    Eur J Health Econ; 2023 Apr; 24(3):321-333. PubMed ID: 35610398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic Burden of Irritable Bowel Syndrome with Diarrhea: Retrospective Analysis of a U.S. Commercially Insured Population.
    Buono JL; Mathur K; Averitt AJ; Andrae DA
    J Manag Care Spec Pharm; 2017 Apr; 23(4):453-460. PubMed ID: 28345443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence, characteristics, and costs of diagnosed homocystinuria, elevated homocysteine, and phenylketonuria in the United States: a retrospective claims-based comparison.
    Sellos-Moura M; Glavin F; Lapidus D; Evans K; Lew CR; Irwin DE
    BMC Health Serv Res; 2020 Mar; 20(1):183. PubMed ID: 32143624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of a national administrative database to guide public decisions: From the système national d'information interrégimes de l'Assurance Maladie (SNIIRAM) to the système national des données de santé (SNDS) in France.
    Tuppin P; Rudant J; Constantinou P; Gastaldi-Ménager C; Rachas A; de Roquefeuil L; Maura G; Caillol H; Tajahmady A; Coste J; Gissot C; Weill A; Fagot-Campagna A
    Rev Epidemiol Sante Publique; 2017 Oct; 65 Suppl 4():S149-S167. PubMed ID: 28756037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and economic burden of obstructive hypertrophic cardiomyopathy in the United States.
    Jain SS; Li SS; Xie J; Sutton MB; Fine JT; Edelberg JM; Gao W; Spertus JA; Cohen DJ
    J Med Econ; 2021; 24(1):1115-1123. PubMed ID: 34493144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
    Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT
    J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology and disease burden of tuberous sclerosis complex in France: A population-based study based on national health insurance data.
    Fagnani F; Laurendeau C; de Zelicourt M; Marshall J
    Epilepsia Open; 2022 Dec; 7(4):633-644. PubMed ID: 36029029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimates of epidemiology, mortality and disease burden associated with progressive fibrosing interstitial lung disease in France (the PROGRESS study).
    Nasser M; Larrieu S; Boussel L; Si-Mohamed S; Bazin F; Marque S; Massol J; Thivolet-Bejui F; Chalabreysse L; Maucort-Boulch D; Hachulla E; Jouneau S; Le Lay K; Cottin V
    Respir Res; 2021 May; 22(1):162. PubMed ID: 34030695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Healthcare resource utilization and costs in 23-25-year-old women with human papillomavirus (HPV) associated anogenital diseases in Germany - a retrospective analysis of statutory health insurance claims data.
    Reuschenbach M; Mihm S; Wölle R; Schneider KM; Jacob C; Greiner W; Hampl M; Goodman E
    BMC Health Serv Res; 2022 Aug; 22(1):1002. PubMed ID: 35932066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comorbidities in people living with HIV: An epidemiologic and economic analysis using a claims database in France.
    Pourcher V; Gourmelen J; Bureau I; Bouee S
    PLoS One; 2020; 15(12):e0243529. PubMed ID: 33332394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.